Biotechnology
CRISPR-Cas technology: balancing efficiency and safety
Research
ETH Zurich
ETH Zurich researchers have uncovered a serious side effect of using the CRISPR-Cas gene scissors. A molecule designed to make the process more efficient destroys parts of the genome.
Using CRISPR to decipher whether gene variants lead to cancer
Research
ETH Zurich
Researchers at ETH Zurich have combined two gene editing methods. This enables them to quickly investigate the significance of many genetic mutations involved in the development and treatment of cancer.
AI tool maps out cell metabolism with precision
Research
EPFL
Scientists at EPFL have developed an AI tool that creates detailed models of cellular metabolism, making it easier to understand how cells function. 
Mini-organs with big potential
Research
ETH Zurich
Organoids grown from human stem cells can help provide answers to important medical questions. In a partnership that looks set to profit both sides, ETH professor Barbara Treutlein has teamed up with pharma giant Roche to advance research in this area.
A big step in joint research
Research
ETH Zurich
Surprisingly little is actually known about how the knee works. ETH professor Bill Taylor plans to change this with a unique technology and a new 22-metre-long experimental facility.  
Rapid early detection of drug resistance in cancer patients
TechTransfer
EPFL
Parithera, an EPFL spin-off, has developed a system that lets doctors detect drug resistance in cancer patients early on, saving precious time and preventing the unnecessary use of treatments with onerous side effects.
Page 1 of 9